Roundtable Discussion: Matching PKD Therapies to Genetic Drivers to Advance Precision Treatment & Reach Mutation-Defined Patient Populations
11:30 am - Tuesday 16th March 2027
- Characterizing pathogenic mutations and variants of uncertain significance to improve patient selection
- Expanding genetic testing to create trial-ready populations for mutation-specific therapeutics
- Connecting genotype to therapeutic response to support increasingly personalized development programs